Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2000
11/09/2000WO2000009166A3 Phosphorylated polymers and conjugates thereof
11/09/2000DE19919751A1 Stabile, wäßrige Dispersionen und stabile, wasserdispergierbare Trockenpulver von Xanthophyllen, deren Herstellung und Verwendung Stable, aqueous dispersions and stable, water-dispersible dry powder of xanthophylls, their preparation and use
11/09/2000CA2372947A1 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
11/09/2000CA2372946A1 Asialocytokines and treatment of liver disease
11/09/2000CA2372907A1 Zymogen activation system
11/09/2000CA2372841A1 Amplification of folate-mediated targeting to tumor cells using polymers
11/09/2000CA2372834A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2372229A1 Folic acid supplement
11/09/2000CA2372225A1 Anti-nausea compositions and methods
11/09/2000CA2372214A1 Modified exendins and exendin agonists
11/09/2000CA2371483A1 Liposome compositions for improved drug retention
11/09/2000CA2371427A1 Parenteral pharmaceutical composition containing humanized monoclonal antibody fragment and stabilizing method thereof
11/09/2000CA2371231A1 Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate
11/09/2000CA2369550A1 Methods and formulations for targeting infectious agents bearing host cell proteins
11/09/2000CA2368801A1 Conjugates as therapies for cancer and prostate diseases
11/09/2000CA2368748A1 X-ray guided drug delivery
11/09/2000CA2365900A1 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
11/09/2000CA2365235A1 Cleaning compositions and tablets
11/08/2000EP1050310A1 Minoxidil-containing liquid preparation composition
11/08/2000EP1050304A1 Liquid ophthalmic preparations
11/08/2000EP1050301A1 Medicinal compositions
11/08/2000EP1050300A2 Selective antibacterial composition
11/08/2000EP1050294A1 Tooth pastes
11/08/2000EP1049793A2 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
11/08/2000EP1049712A2 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns
11/08/2000EP1049678A2 Cyclohexyl and heterocyclyl nucleoside derivatives, method for producing these derivatives, and the use of the derivatives and their oligomers or conjugates in pairing and/or testing systems
11/08/2000EP1049493A1 Surface coating in spatially controlled patterns
11/08/2000EP1049486A1 Glp-1 formulations
11/08/2000EP1049483A1 Method for treating inflammatory diseases using heat shock proteins
11/08/2000EP1049470A1 Extended release tiagabine formulations with reduced side-effects
11/08/2000EP1049469A1 Biodegradable polymer matrices for sustained delivery of anesthetics
11/08/2000EP1049468A1 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
11/08/2000EP1049462A1 Choline esters of fatty acids and their use in the treatment of stroke
11/08/2000EP1049461A2 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction
11/08/2000EP1049459A1 Oral liquid compositions
11/08/2000EP1049454A2 Cosmetic and dermatological preparations containing higher electrolyte concentrations
11/08/2000EP1049453A2 Cosmetic or pharmaceutical preparations with a less sticky feel, containing glycerin esters of alfa-hydroxy carboxylic acids and satured fatty acids
11/08/2000EP1049452A2 Reduced lipid flowable cosmetic or dermatological preparations
11/08/2000EP1049424A1 A drug dosage form based on the teorell-meyer gradient
11/08/2000EP1049388A1 Sweetening agent
11/08/2000EP0935631A4 Grafted rubber-like silicone gel with enhanced oil compatibility and its synthetic process
11/08/2000EP0804155B1 Composition and method for enhancing transdermal electrotransport agent delivery
11/08/2000EP0789564A4 Polynucleotide compositions
11/08/2000EP0652766B1 Human growth hormone aqueous formulation
11/08/2000EP0636029B1 Antibodies specific for carcinoma-associated antigens
11/08/2000CN1272848A Diluting and disintegrating composition, method for obtaining same and use thereof
11/08/2000CN1272796A Polymeric derivatives of camptothecins
11/08/2000CN1272795A Water soluble dry compositions
11/08/2000CN1272793A Method of protecting against chronic infections
11/08/2000CN1272792A Herbal extract composition and method with immune-boosting capability
11/08/2000CN1272789A Pharmaceutical compositions for oral administration of molecular iodine
11/08/2000CN1272787A Sustained-release theophylline tablet
11/08/2000CN1272785A Micro-osmotic controlled drug delivery system
11/08/2000CN1272784A Medicinal compositions for application to mucosa
11/08/2000CN1272365A Physiological active material
11/08/2000CN1272362A Selective antibiotic composition
11/08/2000CN1058191C 疫苗 Vaccine
11/08/2000CN1058150C Topical aromatic releasing compositions
11/07/2000US6143906 Ascorbyl sorbates
11/07/2000US6143901 Complex formation between dsDNA and pyrrole imidazole polyamides
11/07/2000US6143864 Peptides
11/07/2000US6143795 Stable mitoxantrone solutions
11/07/2000US6143793 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions
11/07/2000US6143778 Composition with buffers and nonionic surfactants
11/07/2000US6143775 Physical form of zafirlukast; asthma
11/07/2000US6143726 For treating mycotic infections
11/07/2000US6143716 Liposomal peptide-lipid conjugates and delivery using same
11/07/2000US6143501 Inducing artificial three-dimensional tissues using cell interaction systems such that cultures possessing or developing extracellular matrix are linked via membranes, or are in direct contact with or are mixed with each other
11/07/2000US6143352 pH-modified biocompatible monomer and polymer compositions
11/07/2000US6143329 Aqueous-based pharmaceutical composition
11/07/2000US6143326 Therapy for osteoporosis
11/07/2000US6143325 Ph modulation; sustained release
11/07/2000US6143324 Free-flowable directly compressible starch as binder, disintegrant and filler for compression tablets and hard gelatine capsules
11/07/2000US6143323 Containing n-(4-isopropylcyclohexanecarbonyl)phenylalanine inhydroxypropyl cellulose
11/07/2000US6143322 Method of treating humans with opioid formulations having extended controlled release
11/07/2000US6143319 Transdermal therapeutic system containing estradiol
11/07/2000US6143318 Antimicrobial composition composed of controlled release glasses
11/07/2000US6143314 Thermoplastic resin
11/07/2000US6143280 Color containing silica resistant to dye migration and method of making the same
11/07/2000US6143278 Topical administration of opioid analgesic agent in admixture with skin or mucosal specific penetration enhancer to produce localized analgesic effect in skin or mucosal tissue without transdermal migration of opiod agent
11/07/2000US6143276 Methods for delivering bioactive agents to regions of elevated temperatures
11/07/2000US6142972 Method and apparatus for the delivery of elongate solid drug compositions
11/07/2000CA2046893C Protein coupling to lipid vesicles
11/07/2000CA2011290C A moderated spun fibrous system and method of manufacture
11/03/2000CA2270600A1 Method and formulations for the treatment of diseases, particularly those caused by human immunodeficiency virus and leishmania
11/02/2000WO2000065034A2 Pseudotyped retroviral vector for gene therapy of cancer
11/02/2000WO2000065024A2 Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules
11/02/2000WO2000064954A1 Polymeric encapsulation system promoting angiogenesis
11/02/2000WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf
11/02/2000WO2000064940A1 Insulin crystals for pulmonary administration
11/02/2000WO2000064937A1 Inactivated cytokines for immunisation
11/02/2000WO2000064929A1 Membrane disruptive peptides covalently oligomerized
11/02/2000WO2000064916A1 Crystallization of glucopyranosylalditols, crystalline glucopyranosylalditol product and use thereof
11/02/2000WO2000064858A1 Bipolar lipids and their use for the delivery of bioactive substances
11/02/2000WO2000064854A1 Conjugated fatty acid esters
11/02/2000WO2000064575A1 Method for production of microcapsules
11/02/2000WO2000064516A1 Controlled delivery of bisphosphonates
11/02/2000WO2000064487A2 Delivery of antimicrobial toxins
11/02/2000WO2000064486A2 Enzymatically activated polymeric drug conjugates
1 ... 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 ... 1712